Cryptococcosis-related deaths and associated medical conditions in the United States, 2000-2010

被引:20
作者
Barragan, Noel C. [1 ]
Sorvillo, Frank [2 ]
Kuo, Tony [1 ,2 ,3 ]
机构
[1] Los Angeles Cty Dept Publ Hlth, Div Chron Dis & Injury Prevent, Los Angeles, CA 90010 USA
[2] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Family Med, Los Angeles, CA 90095 USA
关键词
Cryptococcosis; epidemiology; fungal; infectious; disease; human; SEROLOGIC EVIDENCE; NEOFORMANS; AIDS;
D O I
10.1111/myc.12238
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Cryptococcosis is an invasive mycotic infection primarily affecting immunocompromised individuals. The objective of this study was to describe cryptococcosis mortality and associated medical conditions in the US for the period 2000-2010. Cryptococcosis-related deaths were identified from the national multiple-cause-of-death dataset. Mortality trends and comparison analyses were performed on overall cases of cryptococcosis and by subset [i.e. clinical manifestations of disease and human immunodeficiency virus (HIV) status]. A matched case-control analysis was also conducted to describe the associations between this disease and comorbid medical conditions. A total of 3210 cryptococcosis-related deaths were identified. Cerebral cryptococcosis was the most commonly reported clinical manifestation of the disease. Approximately one-fifth of the decedents (n=616) had a co-diagnosis of HIV. Mortality rates were highest among men, blacks, Hispanics, Native Americans and older adults. Poisson regression analysis indicated a 6.52% annual decrease in mortality rates for the study period. HIV (MOR=35.55, 95% CI 27.95-45.22) and leukaemia (MOR=16.10, 95% CI 11.24-23.06) were highly associated with cryptococcosis-related deaths. Cryptococcosis mortality declined significantly during 2000-2010. However, the disease continues to cause appreciable mortality in the US. With the majority of decedents having no HIV co-diagnosis, there is still much to be learned about the epidemiology of this mycosis.
引用
收藏
页码:741 / 746
页数:6
相关论文
共 18 条
  • [1] Anderson R N, 1998, Natl Vital Stat Rep, V47, P1
  • [2] [Anonymous], 2011, INT STAT CLASS DIS R, V2
  • [3] [Anonymous], 2010, HLTH US 2010 SPEC FE
  • [4] Cryptococcal meningitis
    Bicanic, T
    Harrison, TS
    [J]. BRITISH MEDICAL BULLETIN, 2005, 72 (01) : 99 - 118
  • [5] What makes Cryptococcus neoformans a pathogen?
    Buchanan, KL
    Murphy, JW
    [J]. EMERGING INFECTIOUS DISEASES, 1998, 4 (01) : 71 - 83
  • [6] Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infections Diseases Division of Foodborne Waterborne and Environmental Diseases, 2014, FUNG DIS CRYPT STAT
  • [7] Antibody response to Cryptococcus neoformans proteins in rodents and humans
    Chen, LC
    Goldman, DL
    Doering, TL
    Pirofski, LA
    Casadevall, A
    [J]. INFECTION AND IMMUNITY, 1999, 67 (05) : 2218 - 2224
  • [8] Dixit A, 2009, INTERDISCIP PERSPECT, V2009, DOI DOI 10.1155/2009/840452
  • [9] Serologic evidence for Cryptococcus neoformans infection in early childhood
    Goldman, DL
    Khine, H
    Abadi, J
    Lindenberg, DJ
    Pirofski, L
    Niang, R
    Casadevall, A
    [J]. PEDIATRICS, 2001, 107 (05) : E66
  • [10] Cryptococcus gattii infections and virulence
    Harris J.R.
    Galanis E.
    Lockhart S.R.
    [J]. Current Fungal Infection Reports, 2014, 8 (1) : 81 - 89